Pharmacy and Therapeutics Committee Preparedness Plan for COVID-19-Reference-Cited by-同舟云学术

Pharmacy and Therapeutics Committee Preparedness Plan for COVID-19

Published:2020-05-01 Issue:2 Volume:3 Page:55-64
ISSN:2589-9449
Container-title:Global Journal on Quality and Safety in Healthcare
language:en
Short-container-title:

Author:

Abu Esba Laila Carolina¹²,Al-Abdulkarim Hana Abdullah¹³,Alrushidan Ahmed⁴,Al Harbi Mohammed⁵⁶

Affiliation:

1. Clinical Pharmacist, Ministry of National Guard, Health Affairs, and Joint Appointment Lecturer of Pharmacy Practice at King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia

2. King Abdullah International Medical Research Centre, Riyadh, Saudi Arabia

3. Drug Policy and Economic Centre, Ministry of National Guards Health Affairs, Saudi Arabia

4. Corporate Pharmaceutical Planning, Logistic and Contract Management, National Guard Health Affairs, Riyadh, Saudi Arabia

5. Department of Anesthesia, King Abdulaziz Medical City, Ministry of National Guard, Riyadh, Saudi Arabia

6. Joint Appointment Assistant Professor of Anesthesiology, King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Centre, Riyadh, Saudi Arabia

Abstract

ABSTRACT As the Pharmacy and Therapeutics (P&T) committee acts as an advisory committee on therapeutic options, it is important during pandemics, such as the current Coronavirus disease 2019 pandemic, to quickly search the evidence, be able to select the most appropriate therapies despite the limited evidence, and make appropriate decisions related to which drugs to procure and stock. Potential therapies and recommendations to the P&T committee at a large healthcare institution as means of a preparedness plan are reviewed here.

Publisher

Innovative Healthcare Institute

Link

http://meridian.allenpress.com/innovationsjournals-JQSH/article-pdf/3/2/55/2870843/i2589-9449-3-2-55.pdf

Reference40 articles.

1. World Health Organization. Coronavirus Disease (COVID-19) - events as they happen. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen.Accessed March 12,2020.

2. ESRI. 2020. Novel Coronavirus (COVID-19) situation. https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd.Accessed March 12,2020.

3. Porcheddu R, Serra C, Kelvin D, Kelvin, N, Rubino S. Similarity in case fatality rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. J Infect Dev Ctries. 2020; 14: 125– 128.

4. Ministry of Health. MOH News - MOH reports first case of Coronavirus infection. https://www.moh.gov.sa/en/Ministry/MediaCenter/News/Pages/News-2020-03-02-002.aspx.Accessed March 12,2020.

5. Ebrahim SH, Memish ZA. Saudi Arabia‘s measures to curb the COVID-19 outbreak: temporary suspension of the Umrah pilgrimage. J Travel Med. 2020; taaa029,DOI:10.1093/jtm/taaa029.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lomitapide: A Medication Use Evaluation and a Formulary Perspective;Global Journal on Quality and Safety in Healthcare;2024-05-01

2. Can’t find the antidote: A root cause analysis;Frontiers in Pharmacology;2022-09-06

3. Pharmacoeconomic Trends, Applications, and Potential Developments;Global Journal on Quality and Safety in Healthcare;2020-05-01